A Prospective, Randomized, Multicenter, Open, Blinded Endpoint (PROBE), Clinical Trial to Assess the Renal and Humoral Effects of Sevelamer Carbonate in Patients With Chronic Kidney Disease and Residual Proteinuria Despite Best Available Treatment
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Sevelamer (Primary) ; Irbesartan; Ramipril
- Indications Proteinuria
- Focus Therapeutic Use
- Acronyms ANSWER
- 09 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 20 Mar 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
- 04 Nov 2013 New trial record